Effects of erythropoietin administration on iron status in patients with ST-elevation myocardial infarction who underwent successful percutaneous coronary intervention

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1644-1645

  Suzuki, Tomoyasu ^a   Toba, Ken ^a   Kato, Kiminori ^a   Ozawa, Takuya ^a   Suzuki, Hiroshi ^b   Tomosugi, Naohisa ^c   Saitoh, Hideki ^d   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

EPO AMI 1 Study; Erythropoietin; Ferritin; Hepcidin; STEMI

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEPCIDIN; HEPCIDIN 25; INTERLEUKIN 6; IRON; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; IRON BLOOD LEVEL; IRON STORAGE; LETTER; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EPO/AMI-1 STUDY; ERYTHROPOIETIN; FERRITIN; HEPCIDIN; STEMI;

ADULT; AGED; COHORT STUDIES; ERYTHROPOIETIN; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84881478098     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.026     Document Type: Article

References (10)

1. T.P. Tuomainen, K. Punnonen, K. Nyyssönen, and J.T. Salonen Association between body iron stores and the risk of acute myocardial infarction in men Circulation 97 1998 1461 1466
2. T. Suzuki, K. Toba, K. Kato, T. Ozawa, M. Higasimura, and T. Kitajima Serum ferritin levels adversely affect cardiac function in patients with ST-elevation myocardial infarction who underwent successful percutaneous coronary intervention Int J Cardiol 167 1 July 15 2013 286 288
3. J.D. Griffiths, L.J. Campbell, and I.W. Woodruff Acute changes in iron metabolism following myocardial infarction Am J Clin Pathol 84 1985 649 654
4. T. Ozawa, K. Toba, and H. Suzuki Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study Circ J 74 2010 1415 1423
5. N. Yoshimura, K. Toba, T. Ozawa, Y. Aizawa, and T. Hosoya A novel program to accurately quantify infarction volume by (99m)Tc MIBI SPECT, and its application for re-analyzing the effect of erythropoietin administration in patients with acute myocardial infarction Circ J 74 2010 2741 2743
6. N. Tomosugi, H. Kawabata, and R. Wakatabe Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System Blood 108 2006 1381 1387
7. S. Rivera, E. Nemeth, V. Gabayan, M.A. Lopez, D. Farshidi, and T. Ganz Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs Blood 106 2005 2196 2199
8. M. Isoda, H. Hanawa, and R. Watanabe Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction J Nutr Biochem 21 2010 749 756
9. N. Mewton, C.Y. Liu, P. Croisille, D. Bluemke, and J.A. Lima Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
10. H. Suzuki, K. Toba, and K. Kato Serum hepcidin-20 is elevated during the acute phase of myocardial infarction Tohoku J Exp Med 218 2009 93 98